Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 11/9/2025

Asthma Management Guidelines

Introduction to Asthma Action Plan

  • The American Academy of Allergy, Asthma, and Immunology recommends that all patients with asthma must receive a written asthma action plan that includes daily management instructions, recognition of worsening symptoms, medication adjustments, and clear criteria for seeking emergency care 1, 2, 3

Core Components of the Action Plan

  • The Global Initiative for Asthma (GINA) suggests daily preventive actions, including taking long-term controller medications every day as prescribed, avoiding identified triggers, and monitoring symptoms 1, 2, 4
  • The National Asthma Education and Prevention Program recommends using as-needed low-dose ICS-formoterol, which reduces severe exacerbations by ≥60% compared to SABA alone 3

Warning Signs and Emergency Care

  • The American College of Allergy, Asthma, and Immunology states that warning signs of worsening asthma include increased cough, wheeze, chest tightness, or shortness of breath, and danger signs requiring immediate emergency care include severe breathlessness, no improvement or worsening despite taking reliever medication, and peak flow <50% of personal best 1, 2, 5, 7

Medication Adjustment Algorithm

  • The American Thoracic Society recommends verifying medication adherence, inhaler technique, and trigger avoidance before increasing medications, and considering reducing treatment after 3 months of good control 6, 8

High-Risk Patients Requiring Intensive Monitoring

  • The National Heart, Lung, and Blood Institute suggests that patients at increased risk of asthma-related death need special attention, including those with previous severe exacerbation, two or more hospitalizations, or using >2 canisters of SABA per month 5

Follow-Up and Monitoring Schedule

  • The European Respiratory Society recommends regular assessment at each visit, including days per week with symptoms and nighttime awakening, days per week with activity limitation, number of puffs of reliever medication used daily, and review of peak flow chart if patient monitors at home 1, 2